Navigation Links
Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322

ntrols its patented PROfusion protein design engine. Adnexus has over 100 issued and pending patent properties relating to Adnectins and PROfusion.

About Adnexus Therapeutics

Adnexus Therapeutics is focused on generating vital medicines through the discovery, development, and commercialization of its broadly applicable new therapeutic class, Adnectins. Adnexus' lead product candidate, CT-322, is in Phase 1 clinical development in oncology in the United States. The company also has a pipeline of other Adnectin products in preclinical research across multiple therapeutic areas. Adnectins are designed and optimized using PROfusion, the company's patented protein design engine that uniquely enables rapid optimization of protein therapeutics. The company is funded by four leading venture capital firms: Atlas Venture, Flagship Ventures, Polaris Venture Partners, and Venrock Associates.

This news release contains certain forward-looking statements that involve risks and uncertainties. Such statements are only predictions and the company's actual results may differ materially from those anticipated in these forward-looking statements. Factors that may cause such differences include the timing of clinical trials, the risk that products that appeared promising in early research and clinical trials do not demonstrate safety or efficacy in clinical trials and the risk that the company will not obtain approval to market its products.

Adnectin(TM), Adnexus(TM) Therapeutics and PROfusion(TM) are trademarks of Adnexus(TM) Therapeutics, Inc. Adnexus(SM) Therapeutics is a service mark of Adnexus(TM) Therapeutics.

For more information, please visit www.adnexustx.com

Contact

Corporate Contacts
Adnexus Therapeutics, Inc.
Katrine Bosley, 781-891-3745
Vice President Business Development
pr@adnexustx.com
or
Media Contacts

'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:4/24/2015)... N.C. , April 24, 2015 ... are establishing employee groups around the world to ... round-the-clock business hours. While there are many areas ... leaders must examine which best practices are necessary ... excellence. According to research by ...
(Date:4/24/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/pmbmv2/global_biobanking ... Biobanking Market 2015-2019" report to their offering. ... grow at a CAGR of 7.07% over the period ... divided into two segments: Equipment and Consumables. This report ... the Global Biobanking market for the period 2015-2019. ...
(Date:4/24/2015)... YORK , April 24, 2015 ... (NIAID) (part of the National Institutes of Health ... to nine research projects for the development of ... of  recent HAI outbreaks at U.S. health facilities ... supporting research into rapid, multiplexed and effective tests ...
Breaking Medicine Technology:Work Around the Clock: Building Effective Global Capabilities 2Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2Kalorama: NIAID Rewards HAI Innovators with Grants 2Kalorama: NIAID Rewards HAI Innovators with Grants 3Kalorama: NIAID Rewards HAI Innovators with Grants 4
... Limited (ASX:CIR, OTCQX:CKDXY) announced today that it has commenced ... human monoclonal antibody against VEGF-C, VGX-100, at a leading ... study will examine the safety and tolerability of escalating ... who have no other standard treatment options both as ...
... LOUIS, Jan. 6, 2012  Pepex Biomedical, Inc., a privately held ... known as " CCM™ ", announced today it has reached ... division of West Pharmaceuticals Services, Inc. , to be ... systems and sensor modules.  The seven year contract also includes ...
Cached Medicine Technology:Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients 2Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients 3Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients 4Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients 5Pepex Biomedical Signs Seven Year Deal to Manufacture "Trio™" 2Pepex Biomedical Signs Seven Year Deal to Manufacture "Trio™" 3
(Date:4/26/2015)... April 26, 2015 Forbes Living ... city is one which is synonymous with clean beaches, sparkling ... and education are major economic influencers in the city on ... dynamic talk show are pleased to announce the show will ... 26 at 3:00 PM PDT. Tune in to find out ...
(Date:4/26/2015)... Memphis, TN (PRWEB) April 26, 2015 ... plans to grow throughout the Southeast. MidSouth Pain Treatment ... clinic locations in Cordova, Southaven, Oxford and Jackson, two ... CLIA-certified laboratory in the Southaven and Cordova locations. , ... said ”I went into medicine to help people, ...
(Date:4/25/2015)... Portland, ME (PRWEB) April 26, 2015 ... a Canadian based integrative healthcare event. The Integrative ... taking place October 23-24, 2015 at the Sheraton ... Healthcare Symposium Canada is one of the most ... a clinically relevant, evidenced-based CME program. The event ...
(Date:4/25/2015)... In observance of World Malaria Day, today thousands ... a two-year pledge by the United Nations Foundation’s Nothing ... million bednets by 2016. This ambitious $10 million pledge ... protect children, refugees, and families displaced by conflict in ... a large surge in refugee families displaced by conflict ...
(Date:4/25/2015)... 2015 In the United States alone, ... needed treatment for an illicit drug or ... and Mental Health Services Administration’s Survey on Drug Use ... numbers are harrowing stories of men and women whose ... David H. Kerr , founder and retired president ...
Breaking Medicine News(10 mins):Health News:Forbes Living TV Will Air in San Diego, California 2Health News:Growing Pains for MidSouth Pain Treatment Center 2Health News:Integrative Healthcare Event launching in Canada 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 4Health News:New Book Features Powerful Stories of People Who Overcame Addiction 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 3
... guard this hospital, but I can,t afford to see ... at Kaiser Sunset Medical Center in Los Angeles OAKLAND, ... against unfair labor practices and slashed health benefits by ... Oakland and Los Angeles today. Workers chanted, marched, and ...
... Issued in Massachusetts General Hospital LawsuitVANCOUVER, May 21 /PRNewswire-FirstCall/ ... QLT) announced that on May 21, 2009, the District ... on QLT,s Motion to Dismiss all the claims filed ... General Hospital ("MGH") in its lawsuit against QLT. In ...
... Action to Improve Delivery of PMTCTGENEVA, May 21 ... in Geneva, members of the International Treatment Preparedness Coalition ... approximately 100 staff members of UNAIDS and WHO to ... Failing Women, Failing Children: HIV, Vertical Transmission and ...
... 21 As a health care practitioner, Trina Hammack ... with ovarian cancer, she knew her prognosis was bleak. ... Mexico offering effective new treatments for ovarian cancer. ... thousands of Americans diagnosed with cancer will travel to ...
... YORK, May 21 Immtech Pharmaceuticals, Inc. (OTC: IMMP) ... its common stock on the Pink OTC Markets quotation ... the ticker symbol "IMMP".As announced previously, on March 27, ... (the "Exchange") of its intention to initiate proceedings to ...
... MarketBERKELEY, Calif., May 21 In spite of fewer openings ... economic recession -- there is still a nursing shortage, according ... Institute for Nursing & Health Care (CINHC)."About half of all ... is just one factor in the job market for registered ...
Cached Medicine News:Health News:Security Officers Who Protect Kaiser Hospitals Rally With Community Supporters for Access to Affordable Healthcare 2Health News:QLT Announces Court Response to Motion to Dismiss and Removal of Case to Federal Court 2Health News:QLT Announces Court Response to Motion to Dismiss and Removal of Case to Federal Court 3Health News:AIDS Treatment Activists Push UNAIDS and WHO to Meet Commitments to Reduce HIV in Women and Newborns 2Health News:AIDS Treatment Activists Push UNAIDS and WHO to Meet Commitments to Reduce HIV in Women and Newborns 3Health News:The Diagnosis Every Woman Dreads - Ovarian Cancer 2Health News:The Diagnosis Every Woman Dreads - Ovarian Cancer 3Health News:Immtech to be Listed on OTC Market 2Health News:Hard Times for Nursing Hires Doesn't Signal End to Shortage According to California Institute for Nursing & Health Care 2
... Unparalleled Comfort Pick one of our pipettors ... the trigger and ejector positionsright where they should ... are ergonomically designed to help avoid repetitive stress ... Productivity In The Palm Of Your Hand ...
... for Unparalleled Comfort Pick one of our ... Notice the trigger and ejector positionsright where they ... pipettors are ergonomically designed to help avoid repetitive ... Productivity In The Palm Of Your Hand ...
... Ergonomic Design for Unparalleled Comfort Pick ... Notice the balance. Notice the trigger and ejector ... Thats because our pipettors are ergonomically designed to ... hours of pipetting. Productivity In The Palm ...
... The total ergonomic solution and best value ... feather touch action and ultra lightweight design ... tip ejection with long, lever tip ejector ... , Accepts universal tips or for greater ...
Medicine Products: